The Future Revolution of Dadiah and Metformin to Repairing Gut Histopathology by Promoting IgA Expression of Diabetic Rats

Diabetic nephropathy (DN) is often associated with problems in the digestive system. Many studies have shown that probiotics contained in Dadiah play a role in improving gut health. In addition, probiotics offer therapeutic benefits when combined with metformin. There doesn’t seem to be a study that looks at how Dadiah and metformin work together to improve the histopathology of the gut in a rat model of diabetes mellitus by raising the expression of immunoglobulin A (IgA). This study aimed to evaluate the synergistic effect between the combination of Dadiah and metformin in improving gut histopathology in a rat model of diabetes mellitus through increased expression of immunoglobulin A (IgA). This experimental study used adult Wistar Rattus norvegicus rats as the animal model. We randomly divided 35 rats into 7 treatment groups: 2 control groups and 5 treatment groups, each given a different combination of treatments. The Barthel-Manja score was used to determine what was wrong with 5 copies of each sample, and immunohistochemistry was used to determine how much IgA was in the gut tissue. Taking Dadiah and metformin together resulted in more IgA expression and significantly better intestinal histopathology scores compared to taking them separately. Combining Dadiah and metformin has the potential to usher in a new era in diabetes management. This is because both works together to improve the integrity of the intestinal epithelium by enhancing the mucosal immune response. This approach not only contributes to blood glucose control but also supports intestinal immune function, highlighting the potential of dietary intervention in comprehensive diabetes management. HIGHLIGHTSUsing Dadiah and metformin together in a new way has shown tremendous promise in raising the level of IgA, which is an important part of the mucosal immune system. This combination shows promise as an effective adjuvant therapy for diabetic nephropathy (DN), offering new hope for patients with this condition. GRAPHICAL ABSTRACT